Tetracycline
Acnedur, Aknecyclin, Aknesilex, Durumex % · ATC code D06AA04
Also known as: Tetracyclin, Tetrasiklin · Brand names: Acnedur, Aknecyclin, Aknesilex, Durumex %, Imex Merhem, Noacne
- Key facts
- Active substance
- Tetracycline
- ATC code
- D06AA04
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-27
Key facts
Tetracycline is a tetracycline-class antibacterial. Per the US prescribing information, it treats infections caused by susceptible organisms, including respiratory, skin and rickettsial infections, and is used adjunctively in severe acne.
What it is used for
- Upper and lower respiratory tract infections caused by susceptible organisms
- Skin and soft tissue infections
- Rickettsial infections (e.g. Rocky Mountain spotted fever, typhus, Q fever) and psittacosis
- Further indications, including syphilis, gonorrhea, chlamydial infection, brucellosis and acne, in the full text
Dosing
- Adults: usual 1 gram daily as 500 mg twice a day or 250 mg four times a day; up to 500 mg four times a day for severe infections.
- Pediatric patients above eight years: 25 mg/kg to 50 mg/kg daily in four equal doses.
- Streptococcal infections: continue therapy for 10 days.
- Chlamydia trachomatis infections in adults: 500 mg four times a day for at least seven days.
- Renal impairment: decrease total dosage; take with adequate fluid.
Contraindications
- Hypersensitivity to any of the tetracyclines
Important warnings
- Permanent tooth discoloration and enamel hypoplasia with use during tooth development (last half of pregnancy to age 8 years)
- Clostridium difficile associated diarrhea
- Photosensitivity; discontinue at the first evidence of skin erythema
- Intracranial hypertension (pseudotumor cerebri)
- Fixed drug eruptions; discontinue immediately for severe skin reactions
Side effects
- Gastrointestinal: anorexia, nausea, vomiting, diarrhea, glossitis
- Esophagitis and esophageal ulceration, especially when taken just before bed
- Rashes, onycholysis, hepatotoxicity, increased BUN
- Hypersensitivity up to anaphylaxis; blood count changes
Interactions
- Antacids with aluminum, calcium or magnesium, and iron, zinc, sodium bicarbonate, food and dairy reduce absorption
- Penicillin: avoid concomitant use
- Anticoagulants: dose may need downward adjustment
- Oral contraceptives may be less effective; avoid isotretinoin
Pregnancy and breastfeeding
- Use in the last half of pregnancy may cause permanent tooth discoloration.
- Nursing: decide whether to discontinue the drug given potential serious reactions in nursing infants.
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Turkey
- AcnedurADEKA İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- AknecyclinBEYMED İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- AknesilexHELBA İLAÇ İÇ VE DIŞ SAN. TİC. A.Ş. · 1 register entry
- Durumex %ARGİS İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- Imex MerhemASSOS İLAÇ KİMYA GIDA ÜRÜNLERİ ÜRETİM VE TİC. A.Ş. · 3 register entries
- NoacneDİNÇSA İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 14 more European countries
- Belgium
- Tetralysal
- Bulgaria
- Тетрациклин Абр, Тетрациклин Актавис, Тетрациклин Вижън Антибиотик-Разград
- Cyprus
- Medocycline
- Denmark
- Tetracyclin Actavis, Tetracyklin "dak", Tetracyklin Dak, Tetralysal
- Finland
- Oricyclin
- France
- Tetralysal
- Greece
- Muvito, Tetrac, Tracyclin
- Italy
- Ambramicina, Tetralysal
- Luxembourg
- Tetralysal
- Netherlands
- Tetracycline Hcl Cf
- Norway
- Tetracyclin Actavis, Tetralysal
- Poland
- Tetracyclinum Chema, Tetracyclinum Tzf
- Romania
- Tetraciclina Atb, Tetraciclină Arena, Tetraciclină Atb
- Sweden
- Tetralysal
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. tetracycline hydrochloride (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.) – Prescribing Information, 2025-03-18. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eaa5b1bd-0927-46e4-b941-32fcc492d258
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.